Review of diseases with restricted diffusion on magnetic resonance imaging of the brain

Česká verze

Authors: Z. Sedláčková ¹; T. Dorňák ²; E. Čecháková ¹; S. Buřval ¹; M. Heřman ¹
Authors place of work: Radiologická klinika LF UP a FN Olomouc ¹; Neurologická klinika LF UP a FN Olomouc ²
Published in the journal: Cesk Slov Neurol N 2018; 81(5): 539-545
Category: Přehledný referát
doi: https://doi.org/10.14735/amcsnn2018539

Summary

There are a lot of diseases that can show restricted diffusion on brain MRI. While it is almost always present in some of them, it can be seen only occasionally in others, in which case it is usually associated with a more severe prognosis. Additional MRI sequences and clinical presentation aid in the differential diagnosis. The aim of this review is to enlist and describe diseases that can present with restricted diffusion on brain MRI. Restricted diffusion is most often found in acute ischemia and it is also typically present in an abscess or empyema as well as in lymphomas and Creutzfeldt-Jacob disease. It can also be found in highly cellular tumors, certain metastases, diffuse axonal injury, acute disseminated encephalomyelitis, encephalitis, posterior reversible encephalopathy syndrome, Wernicke’s encephalopathy, Marchiafava-Bignami syndrome, osmotic demyelination syndrome, hypo-/ hyperglycemia, Rathke’s cleft cysts, acute-stage Wilson’s disease, carbon monoxide poisoning, and, rarely, in MS and epilepsy. Restricted diffusion is assessed on diffusion-weighted images (DWI). It can only be valid in the case of a simultaneous finding of a hypersignal area on DWI with a higher b value (usually b = 1,000) and of a hyposignal area in the same location on apparent diffusion coefficient maps.

Key words:
magnetic resonance imaging –⁠ diffusion magnetic resonance imaging –⁠ brain ischemia –⁠ brain abscess –⁠ brain neoplasms

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Sener RN, Atalar MH. Diffusion-weighted magnetic resonance imaging in the early diagnosis of neonatal adrenoleukodystrophy. J Clin Imaging Sci 2011; 1 : 20. doi: 10.4103/ 2156-7514.78530.

2. Srikanth SG, Chandrashekar HS, Nagarajan K et al. Restricted diffusion in Canavan disease. Childs Nerv Syst 2007; 23(4): 465 –⁠ 468. doi: 10.1007/ s00381-006-0238-9.

3. Mohammad SA, Abdelkhalek HS. Nonketotic hyperglycinemia: Spectrum of imaging findings with emphasis on diffusion-weighted imaging. Neuroradiology 2017; 59(11): 1155 –⁠ 1163. doi: 10.1007/ s00234-017-1913-0.

4. Bhat MD, Prasad C, Tiwari S et al. Diffusion restriction in ethylmalonic encephalopathy –⁠ an imaging evidence of the pathophysiology of the disease. Brain Dev 2016; 38(8): 768 –⁠ 771. doi: 10.1016/ j.braindev.2016.02.014.

5. Nam TS, Oh J, Levy M et al. A novel GFAP mutation in late-onset Alexander disease showing diffusion restriction. J Clin Neurol 2017; 13(4): 426 –⁠ 428. doi: 10.3988/ jcn.2017.13.4.426.

6. Kumakura A, Asada J, Okumura R et al. Diffusion--weighted imaging in preclinical Leigh syndrome. Pediatr Neurol 2009; 41(4): 309 –⁠ 311. doi: 10.1016/ j.pediatrneurol.2009.04.028.

7. Chethan BS, Yugandhara S. Eye of tiger sign in Hallervorden Spatz disease (pantothenate kinase II associated neurodegeneration -⁠ PKAN): a rare case report. Journal of Evolution of Medical and Dental Sciences 2013; 2(50): 9641 –⁠ 9644.

8. Kim JH, Lim MK, Jeon TY et al. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol 2011; 12(1): 15 –⁠ 24. doi: 10.3348/ kjr.2011.12.1.15.

9. Stadnik TW, Demaerel P, Luypaert RR et al. Imaging tutorial: differential diagnosis of bright lesions on diffusion-weighted MR images. Radiographics 2003; 23(1): e7. doi: 10.1148/ rg.e7.

10. Bernstein M, Berger MS. Neuro-oncology: the essentials. 3rd ed. Stuttgart: Thieme Medical Publishers 2014.

11. Žižka J, Tintěra J, Mechl M et al. Protokoly MR zobrazování, pokročilé techniky. Praha: Galén 2015.

12. Seidl Z, Vaněčková M. Diagnostická radiologie. Neuroradiologie. Praha: Grada 2014.

13. Allen LM, Hasso AN, Handwerker J et al. Sequence-specific MR imaging findings that are useful in dating ischemic stroke. Radiographics 2012; 32(5): 1285 –⁠ 1297. doi: 10.1148/ rg.325115760.

14. Thomalla G, Simonsen CZ, Boutitie F et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018; 379(7): 611 –⁠ 622. doi: 10.1056/ NEJMoa1804355.

15. Connelly KL, Chen X, Kwan PF. Bilateral hippocampal stroke secondary to acute cocaine intoxication. Oxf Med Case Reports 2015; 2015(3): 215 –⁠ 217. doi: 10.1093/ omcr/ omv016.

16. Osborn AG, Salzman KL, Barkowivich AJ et al. Diag-nostic Imaging: brain. 2nd ed. Salt Lake City: Amirsys 2010.

17. Hartmann M, Jansen O, Heiland S et al. Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. AJNR Am J Neuroradiol 2001; 22(9): 1738 –⁠ 1742.

18. Holmes TM, Petrella JR, Provenzale JM. Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJR Am J Roentgenol 2004; 183(5): 1247 –⁠ 1252. doi: 10.2214/ ajr.183.5.1831247.

19. Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol 2010; 67(3): 291 –⁠ 297. doi: 10.1001/ archneurol.2010.3.

20. Osborn AG, Ross JS, Salzman KL et al. ExpertDDx: brain and spine. 1st ed. Salt Lake City: Amirsys 2008.

21. Valles FE, Perez-Valles CL, Regalado S et al. Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. AJNR Am J Neuroradiol 2013; 34 : 35 –⁠ 40. doi: 10.3174/ ajnr.A3165.

22. Nasir SS, DeAngelis LM. Update on the management of primary CNS lymphoma. Oncology (Williston Park) 2000; 14(2): 228 –⁠ 234.

23. Mansour A, Qandeel M, Abdel-Razeq H et al. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 2014; 14(1): 22. doi: 10.1186/ 1470-7330-14-22.

24. Koubska E, Weichet J, Malikova H. Central nervous system lymphoma: a morphological MRI study. Neuro Endocrinol Lett 2016; 37(4): 318 –⁠ 324.

25. Jahnke K, Schilling A, Heidenreich J et al. Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients. Am J Neuroradiol 2005; 26(10): 2446 –⁠ 2454.

26. Aygun N, Shah G, Gandhi D. Pearls and pitfalls in head and neck and neuroimaging: variants and other difficult diagnoses. Cambridge: Cambridge University Press 2013.

27. Huang WY, Wen JB, Wu G et al. Diffusion-weighted imaging for predicting and monitoring primary central nervous system lymphoma treatment response. AJNR Am J Neuroradiol 2016; 37(11): 2010 –⁠ 2018. doi: 10.3174/ ajnr.A4867.

28. Meissner B, Kallenberg K, Sanchez-Juan P et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. Am J Neuroradiol 2008; 29(8): 1519 –⁠ 1524. doi: 10.3174/ ajnr.A1122.

29. Saha A, Ghosh SK, Roy C et al. Demographic and clinical profile of patients with brain metastases: a retrospective study. Asian J Neurosurg 2013; 8(3): 157 –⁠ 161. doi: 10.4103/ 1793-5482.121688.

30. Duygulu G, Ovali GY, Calli C et al. Intracerebral metastasis showing restricted diffusion: correlation with histopathologic findings. Eur J Radiol 2010; 74(1): 117 –⁠ 120. doi: 10.1016/ j.ejrad.2009.03.004.

31. Kumar V, Abbas AK, Fausto N et al. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders 2005.

32. Greenberg MS. Handbook of Neurosurgery. 7th ed. New York: Thieme Medical Publishers 2010.

33. Seidl Z, Vaněčková M, Burgetová A et al. Difuzí vážený obraz (DWI) MR u pacientky s encefalitidou způsobenou herpes simplex virem (HSV). Ces Radiol 2008; 62(4): 381 –⁠ 383.

34. Furruqh F, Thirunavukarasu S, Biswas A et al. Complete right cerebral hemispheric diffusion restriction and its follow-up in a case of Rasmussen‘s encephalitis. BMJ Case Rep 2015: pii. doi: 10.1136/ bcr-2015-212256.

35. Sawlani V. Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis. J Neurol Sci 2009; 287(1 –⁠ 2): 221 –⁠ 226. doi: 10.1016/ j.jns.2009.07.010.

36. Schweitzer AD, Parikh NS, Askin G et al. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology 2017; 59(4): 379 –⁠ 386. doi: 10.1007/ s00234-017-1815-1.

37. Sudulagunta SR, Sodalagunta MB, Kumbhat M et al. Posterior reversible encephalopathy syndrome (PRES). Oxf Med Case Reports 2017; 2017(4): omx011. doi: 10.1093/ omcr/ omx011.

38. Brady E, Parikh NS, Navi BB et al. The imaging spectrum of posterior reversible encephalopathy syndrome: a pictorial review. Clin Imaging 2018; 47 : 80 –⁠ 89. doi: 10.1016/ j.clinimag.2017.08.008.

39. Loh Y, Watson WD, Verma A et al. Restricted diffusion of the splenium in acute Wernicke‘s encephalopathy. J Neuroimaging 2005; 15(4): 373 –⁠ 375. doi: 10.1177/ 1051228405279037.

40. Parmanand HT. Marchiafava-Bignami disease in chronic alcoholic patient. Radiol Case Rep 2016; 11(3): 234 –⁠ 237. doi: 10.1016/ j.radcr.2016.05.015.

41. Venkatanarasimha N, Mukonoweshuro W, Jones J. AJR teaching file: symmetric demyelination. Am J Roentgenol 2008; 191 (Suppl 3): S34 –⁠ S36. doi: 10.2214/ AJR.07.7052.

42. Martin TD, Canepa C. Forgetting to remember: hypoglycaemic encephalopathy. BMJ Case Rep 2016; pii: bcr2016217954. doi: 10.1136/ bcr-2016-217954.

43. Bathla G, Policeni B, Agarwal A. Neuroimaging in patients with abnormal blood glucose levels. Am J Neuroradiol 2014; 35(5): 833 –⁠ 840. doi: 10.3174/ ajnr.A3486.

44. Sivaraju L, Anantha Sai Kiran N, Rao AS et al. Giant multi-compartmental suprasellar Rathke‘s cleft cyst with restriction on diffusion weighted images. Neuroradiol J 2017; 30(3): 290 –⁠ 294. doi: 10.1177/ 1971400916682512.

45. Yousaf M, Kumar M, Ramakrishnaiah R et al. Atypical MRI features involving the brain in Wilson‘s desease. Radiol Case Rep 2009; 4(3): 312. doi: 10.2484/ rcr.v4i3.312.

46. Sener RN. Acute carbon monoxide poisoning: diffusion MR imaging findings. Am J Neuroradiol 2003; 24(7): 1475 –⁠ 1477.

47. Foroughi AA, Salahi R, Nikseresht A et al. Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis. Neuroradiol J 2017; 30(4): 347 –⁠ 351. doi: 10.1177/ 1971400916678224.

48. Abdoli M, Chakraborty S, MacLean HJ et al. The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis. Mult Scler Relat Disord 2016; 10 : 97 –⁠ 102. doi: 10.1016/ j.msard.2016.09.006.

49. Jaraba S, Puig O, Miró J et al. Refractory status epilepticus due to SMART syndrome. Epilepsy Behav 2015; 49 : 189 –⁠ 192. doi: 10.1016/ j.yebeh.2015.05.033.

50. Schneider T, Frieling D, Schroeder J et al. Perihematomal diffusion restriction as a common finding in large intracerebral hemorrhages in the hyperacute phase. PLoS One 2017; 12(9): e0184518. doi: 10.1371/ journal.pone.0184518.

51. Renou P, Sibon I, Tourdias T et al. Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences. Cerebrovasc Dis 2010; 29(6): 597 –⁠ 604. doi: 10.1159/ 000312867.